StockData
Xeris Biopharma Holdings, Inc. logo

Xeris Biopharma Holdings, Inc. (XERS) stock

XERSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$16.80+0.10 (+0.60%)

Close on Nov 17, 2026Market cap $3.06BP/E –Yield –

Earnings

Xeris Biopharma's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 1, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$107.20M
+44.1% on a year earlier
Adjusted EPS, Q3 FY2026
$0.06
$0.00 a year earlier
Latest guidance
Raised
Nov 5, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Xeris Biopharma's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Mar 1, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026before the open$107.20M+44.1%$0.06–Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026before the open$92.10M+28.8%-$0.18–Release
Q1 FY2026ended Mar 31, 2026May 7, 2026before the open$83.13M+38.3%$0.01–Release
Q4 FY2025ended Dec 31, 2025Mar 2, 2026before the open$85.81M+42.8%$0.06–Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025before the open$74.38M+37.0%$0.00–Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025before the open$71.50M+48.6%-$0.01–Release
Q1 FY2025ended Mar 31, 2025May 8, 2025before the open$60.12M+48.1%-$0.06–Release
Q4 FY2024ended Dec 31, 2024Mar 6, 2025before the open$60.10M+35.4%-$0.03–Release
Q3 FY2024ended Sep 30, 2024Nov 8, 2024before the open$54.30M+12.4%-$0.11-$0.06Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024before the open$48.10M+26.6%-$0.10–Release
Q1 FY2024ended Mar 31, 2024May 9, 2024before the open$40.60M+22.3%-$0.14–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Xeris Biopharma's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
total revenueFY2026$395.00M – $405.00M$375.00M – $390.00MRaisedNov 5, 2026
total revenueFY2026$385.00M – $390.00M$380.00M – $390.00MRaisedAug 6, 2026

Guidance vs results

The last range Xeris Biopharma gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$285.00M – $290.00M$291.81MΣ4QAbove range

Guidance history

Every forecast Xeris Biopharma put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026total revenueFY2026$395.00M – $405.00MRaised
Aug 6, 2026total revenueFY2026$385.00M – $390.00MRaised
May 7, 2026total revenueFY2026$380.00M – $390.00MNew
Mar 2, 2026Total revenueFY2026$375.00M – $390.00MNew
Nov 6, 2025total revenue guidanceFY2025$285.00M – $290.00MNew
Aug 7, 2025total revenue guidanceFY2025$280.00M – $290.00MRaised
May 8, 2025total revenue guidanceFY2025$260.00M – $275.00MRaised
Mar 6, 2025total revenueFY2025$255.00M – $275.00MNew
Jan 10, 2025total revenueFY2024$203.00MRaised
Nov 8, 2024year-end cashFY2024$68.00M – $72.00MNarrowed
Nov 8, 2024total net revenueFY2024$198.00M – $202.00MRaised
Aug 8, 2024year-end cash balanceFY2024$60.00M – $75.00MRaised
Aug 8, 2024total net revenueFY2024$190.00M – $200.00MRaised
May 9, 2024total revenueFY2024$175.00M – $200.00MRaised
Mar 6, 2024year-end cash, cash equivalents, and short-term investmentsFY2024$55.00M – $75.00MNew
Mar 6, 2024total net revenueFY2024$170.00M – $200.00MNew
Nov 9, 2023revenue guidanceFY2023$160.00M – $165.00MRaised
Aug 8, 20232023 year-end cash balanceFY2023$55.00M – $65.00MLowered
Aug 8, 2023cash utilizationFY2023$57.00M – $67.00MRaised
Aug 8, 2023total net revenueFY2023$145.00M – $165.00MRaised

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Xeris Biopharma filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Update
  4. Update
  5. Results
  6. Update
  7. News
  8. Results
  9. Results
  10. Update
  11. Results
  12. Update
  13. Results
  14. Results
  15. Update

See a number that looks wrong?